Back to Search
Start Over
Pazopanib versus paclitaxel in relapsed urothelial tumors: A randomized phase II study investigating pazopanib versus weekly paclitaxel in relapsed or progressive transitional cell carcinoma of the urothelium (PLUTO)
- Source :
- Journal of Clinical Oncology. 32:TPS4589-TPS4589
- Publication Year :
- 2014
- Publisher :
- American Society of Clinical Oncology (ASCO), 2014.
-
Abstract
- TPS4589 Background: Urothelial cancer (UC) is a chemosensitive disease. There is a clear role for first line, platinum-based chemotherapy in advanced disease, response rates being around 40-50%. Ho...
- Subjects :
- Oncology
Cancer Research
Chemotherapy
medicine.medical_specialty
business.industry
medicine.medical_treatment
Phases of clinical research
Weekly paclitaxel
Pharmacology
medicine.disease
Pazopanib
chemistry.chemical_compound
Transitional cell carcinoma
Paclitaxel
chemistry
Internal medicine
medicine
Advanced disease
Urothelium
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........7bf3348b143b5c59cc0fa7b56c2c143d
- Full Text :
- https://doi.org/10.1200/jco.2014.32.15_suppl.tps4589